Wednesday, January 16, 2019 11:39:24 AM
$DKSC’s cbd is LF
LAS VEGAS, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Dakshidin Corporation (DKSC) announced today that it had signed a Letter of Intent for a worldwide exclusive licensing agreement with GenBio, a biotechnology company based in Brisbane Australia. The agreement is for the exclusive rights to manufacture and distribute an entirely new product based on clinical research of a unique and proprietary superfood that GenBio has carried out over the last five years,
“infused with Dakshidin’s proprietary CBD formulas”
resulting in the only product of its kind on the market.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM